ClinicalTrials.gov
ClinicalTrials.gov Menu

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00049023
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : June 21, 2016
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
O'Dorisio, M S, University of Iowa